ReviewInternational journal of nanomedicine2025
Nanoprobe-Based Near-Infrared II Optical Imaging for Guiding Precision Glioma Therapy.
Review in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Theranostic Smart Bionanosensors for Solid Tumors: Advances, Challenges, and Future Directions.Applied biochemistry and biotechnology · 2026Review
- Synovial microenvironment and fluorescence imaging for early rheumatoid arthritis diagnosis.Journal of pharmaceutical analysis · 2026Review
- Emerging In Vivo Imaging Modalities for Improved Glioblastoma Surgery and Monitoring.Biomedicines · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Glioma is a heterogeneous primary and metastatic tumour of the central nervous system that is highly invasive and destructive, with a poor prognosis and low survival rate. Near-infrared II (NIR-II) fluorescence imaging has revealed significant potential for advancing glioma diagnosis because of its non-invasiveness, high spatiotemporal resolution, reasonable sensitivity, and deep penetration. These imaging techniques have been widely used to guide real-time glioma treatment with high accuracy and efficiency. This review summarised the applications and progress of NIR-II in guiding glioma surgery, targeted drug delivery, photoacoustic therapy, and multimodal therapy. We demonstrated the feasibility and practicality of integrating these technologies into glioma diagnosis and treatment. These technologies have great potential to improve patient prognosis further. Furthermore, this review highlights the challenges of using these technologies in future clinical studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.